Compare Bitdeer Technologies Group (BTDR) vs Novavax Inc (NVAX) Price & Performance

BTDR trades at $9.02, up 3.74% in the last session, with a bearish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $812 million but a net loss of $229 million, missing EPS estimates for four consecutive quarters. Recent news highlights a $4.7 billion AI data center deal in Norway, expanding beyond Bitcoin mining, though gross margins remain pressured.

Outlook is mixed: strong analyst buy consensus (81.82%) and a $22.43 price target suggest upside, but persistent losses, negative cash flow from operations, and high dependency on volatile crypto markets pose significant risks. Investors should weigh growth potential in AI infrastructure against execution challenges and profitability concerns.

NVAX trades at $7.95, up 0.76% on the day, with a bullish technical signal despite mixed indicators. The company reported a net income of $440.30M for 2025, a significant turnaround from prior losses, and has beaten earnings estimates for three consecutive quarters. Recent news highlights Q2 2026 results and a raised revenue outlook, driven by licensing milestones with Sanofi.

The outlook is cautiously optimistic given strong analyst buy ratings (73.92%) and improved financials, but risks include persistent negative cash flows, high debt, and competitive vaccine market pressures. Investment appeal hinges on execution of partnerships and cost management to sustain profitability.